Belantamab mafodotin with pomalidomide and dexamethasone for previously treated multiple myeloma [ID6211]

Draft guidance

Draft guidance (online commenting)

Draft guidance (downloadable version) (PDF 350 KB)

Equality impact assessment (downloadable version) (PDF 120 KB)

Committee papers - ACM1 (PDF 5.37 MB)

Draft scope and provisional stakeholder list comments table (post-referral) (PDF 461 KB)

Final scope (PDF 227 KB)

Equality impact assessment (Scoping) (PDF 126 KB)

Draft matrix post referral (PDF 197 KB)